Integrity of the Antiviral STING-mediated DNA Sensing in Tumor Cells Is Required to Sustain the Immunotherapeutic Efficacy of Herpes Simplex Oncolytic Virus.
Integrity of the Antiviral STING-mediated DNA Sensing in Tumor Cells Is Required to Sustain the Immunotherapeutic Efficacy of Herpes Simplex Oncolytic Virus.
复制标题
肿瘤细胞中抗病毒STING介导的DNA感应的完整性是维持单纯疱疹溶瘤病毒免疫治疗效果所必需的。
DOI:
10.3390/cancers12113407
复制
发表时间:
2020-11-17
期刊:
影响因子:
5.2
通讯作者:
Zambrano N
中科院分区:
文献类型:
--
作者:
Froechlich G;Caiazza C;Gentile C;D'Alise AM;De Lucia M;Langone F;Leoni G;Cotugno G;Scisciola V;Nicosia A;Scarselli E;Mallardo M;Sasso E;Zambrano N
Oncolytic viruses are emerging immunotherapeutics in cancer treatments. The conflicting role of innate immunity in the antitumor activity of oncolytic viruses is still a matter of debate. The STING-dependent DNA sensing axis is considered detrimental for viral replication and cancer cell clearance. Accordingly, we observed that STING loss in tumor cells was associated with improved lytic potential by a herpes-based oncolytic virus. However, STING-knockout cancer cells infected with the oncolytic virus showed impaired immunogenicity, as immunogenic cell death was improperly triggered. In agreement with these observations, STING-knockout tumors raised in a murine syngeneic model were more resistant to a combined treatment of the oncolytic virus with PD-1 blockade. The present study demonstrates the antitumor benefit of antiviral immunity and sheds lights on the mechanisms of immune resistance to oncovirotherapy exerted by STING-loss in tumor cells. The dichotomic contribution of cancer cell lysis and tumor immunogenicity is considered essential for effective oncovirotherapy, suggesting that the innate antiviral immune response is a hurdle for efficacy of oncolytic viruses. However, emerging evidence is resizing this view. By sensing cytosolic DNA, the cyclic GMP-AMP synthase (cGAS) and stimulator of interferon genes (STING) axis can both counteract viral spread and contribute to the elicitation of adaptive immunity via type I interferon responses. In this paper, we analyzed the tumor-resident function of Sting-mediated DNA sensing in a combined approach of oncovirotherapy and PD-1 immune checkpoint blockade, in an immunocompetent murine model. While supporting increased lytic potential by oncolytic HER2-retargeted HSV-1 in vitro and in vivo, Sting-knockout tumors showed molecular signatures of an immunosuppressive tumor microenvironment. These signatures were correspondingly associated with ineffectiveness of the combination therapy in a model of established tumors. Results suggest that the impairment in antiviral response of Sting-knockout tumors, while favoring viral replication, is not able to elicit an adequate immunotherapeutic effect, due to lack of immunogenic cell death and the inability of Sting-knockout cancer cells to promote anti-tumor adaptive immune responses. Accordingly, we propose that antiviral, tumor-resident Sting provides fundamental contributions to immunotherapeutic efficacy of oncolytic viruses.
登录
查看更多内容
影响因子:
7.2
作者:
Michaud M;Xie X;Bravo-San Pedro JM;Zitvogel L;White E;Kroemer G
通讯作者:
Kroemer G
影响因子:
8.8
作者:
Corrales L;Glickman LH;McWhirter SM;Kanne DB;Sivick KE;Katibah GE;Woo SR;Lemmens E;Banda T;Leong JJ;Metchette K;Dubensky TW Jr;Gajewski TF
通讯作者:
Gajewski TF
影响因子:
6.7
作者:
Leoni, Valerio;Vannini, Andrea;Campadelli-Fiume, Gabriella
通讯作者:
Campadelli-Fiume, Gabriella
影响因子:
5.4
作者:
Menotti, Laura;Cerretani, Arianna;Campadelli-Fiume, Gabriella
通讯作者:
Campadelli-Fiume, Gabriella
DOI:
10.1073/pnas.1620433114
发表时间:
2017-01-31
影响因子:
11.1
作者:
Chamoto, Kenji;Chowdhury, Partha S.;Honjo, Tasuku
通讯作者:
Honjo, Tasuku